Geospace Technologies (GEOS)
(Delayed Data from NSDQ)
$11.30 USD
+0.10 (0.89%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $11.25 -0.05 (-0.44%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$11.30 USD
+0.10 (0.89%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $11.25 -0.05 (-0.44%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
The Zacks Analyst Blog Highlights Berkshire Hathaway, Qualcomm, TotalEnergies, Geospace and TSS
by Zacks Equity Research
Berkshire Hathaway, Qualcomm, TotalEnergies, Geospace and TSS are included in this Analyst Blog.
Geospace Technologies (GEOS) Q3 Earnings and Revenues Decline Y/Y
by Zacks Equity Research
Despite strength in the majority of Geospace Technologies (GEOS) segments, overall revenues decline year over year.
How to Invest in Microcaps with Lumpy Revenue
by Mark Zinski
Evaluating microcaps with lumpy revenue requires more valuation effort. Here we highlight two companies which demonstrates this more rigorous process.
Zacks Initiates Coverage of Geospace Technologies With Neutral Recommendation
by Debanjana Dey
Discover why Zacks rates Geospace Technologies as "Neutral," being the first on Wall Street to initiate coverage on the stock. Explore GEOS' strategic shifts and financial health amid market challenges.
Top Stock Reports for Apple, Mastercard & Amgen
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Apple (AAPL), Mastercard (MA) and Amgen (AMGN), as well as two micro-cap stocks Utah Medical Products, Inc. (UTMD) and Bridger Aerospace Group Holdings, Inc. (BAER).